Aguilar-Salinas, Carlos A.
European Atherosclerosis Society
31 papers on CoChatORCID 0000-0001-8517-0241
Most cited papers
- Verified
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Zhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., Gregg, E. W., Bennett, J. E., Solomon, B., Singleton, R. K., et al. (2021) · The Lancet
Blood Pressure and Hypertension StudiesSodium Intake and Health
Cited by 3,902
- Verified
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., Paciorek, C. J., Singh, G., Hajifathalian, K., Bennett, J. E., et al. (2017) · The Lancet
Blood Pressure and Hypertension StudiesSodium Intake and Health
Cited by 2,579
- Verified
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults
Phelps, N. H., Singleton, R. K., Zhou, B., Heap, R. A., Mishra, A., Bennett, J. E., Paciorek, C. J., Lhoste, V. P., Carrillo-Larco, R. M., Stevens, G. A., et al. (2024) · The Lancet
Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 2,544
- Verified
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 979
- Verified
The power of genetic diversity in genome-wide association studies of lipids
Graham, S. E., Clarke, S. L., Wu, K.-H. H., Kanoni, S., Zajac, G. J. M., Ramdas, S., Surakka, I., Ntalla, I., Vedantam, S., Winkler, T. W., et al. (2021) · Nature
Genetic Associations and EpidemiologyLipoproteins and Cardiovascular Health
Cited by 972
- Verified
A saturated map of common genetic variants associated with human height
Yengo, L., Vedantam, S., Marouli, E., Sidorenko, J., Bartell, E., Sakaue, S., Graff, M., Eliasen, A. U., Jiang, Y., Raghavan, S., et al. (2022) · Nature
Genetic Associations and EpidemiologyGenetics and Physical Performance
Cited by 825
- Verified
Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation
Mahajan, A., Spracklen, C. N., Zhang, W., Ng, M. C. Y., Petty, L. E., Kitajima, H., Yu, G. Z., Rüeger, S., Speidel, L., Kim, Y. J., et al. (2022) · Nature Genetics
Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals
Cited by 704
- Verified
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Suzuki, K., Hatzikotoulas, K., Southam, L., Taylor, H. J., Yin, X., Lorenz, K. M., Mandla, R., Huerta-Chagoya, A., Melloni, G. E. M., Kanoni, S., et al. (2024) · Nature
Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals
Cited by 606
- Verified
Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls
Platform, B. G., Flannick, J., DiscovEHR Collaboration, CHARGE, LuCamp, ProDiGY, GoT2D, ESP, SIGMA-T2D, T2D-GENES, et al. (2019) · Nature
Genetic Associations and EpidemiologyGenomics and Rare Diseases
Cited by 304
- Verified
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys
Hajifathalian, K., Ueda, P., Lu, Y., Woodward, M., Ahmadvand, A., Aguilar-Salinas, C. A., Azizi, F., Cifkova, R., Di Cesare, M., Eriksen, L., et al. (2015) · The Lancet Diabetes & Endocrinology
Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention
Cited by 287
- Verified
A Genomewide Admixture Map for Latino Populations
Price, A. L., Patterson, N., Yu, F., Cox, D. R., Waliszewska, A., McDonald, G. J., Tandon, A., Schirmer, C., Neubauer, J., Bedoya, G., et al. (2007) · The American Journal of Human Genetics
Forensic and Genetic ResearchGenetic Associations and Epidemiology
Cited by 282
- Verified
TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects
Garduño-Garcia, J. D. J., Alvirde-Garcia, U., López-Carrasco, G., Padilla Mendoza, M. E., Mehta, R., Arellano-Campos, O., Choza, R., Sauque, L., Garay-Sevilla, M. E., Malacara, J. M., et al. (2010) · European Journal of Endocrinology
Thyroid Disorders and TreatmentsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 268
- Verified
Association of a Low-Frequency Variant in HNF1A With Type 2 Diabetes in a Latino Population
Estrada, K., Aukrust, I., Bjørkhaug, L., Burtt, N. P., Mercader, J. M., García-Ortiz, H., Huerta-Chagoya, A., Moreno-Macías, H., Walford, G., Flannick, J., et al. (2014) · JAMA
Genetic Associations and EpidemiologyDiabetes and associated disorders
Cited by 259
- Verified
Exercise increases serum fibroblast growth factor 21 (FGF21) levels
Cuevas-Ramos, D., Almeda-Valdés, P., Meza-Arana, C. E., Brito-Córdova, G., Gómez-Pérez, F. J., Mehta, R., Oseguera-Moguel, J., & Aguilar-Salinas, C. A. (2012) · PLoS ONE
Fibroblast Growth Factor ResearchPhysical Activity and Health
Cited by 178
- Verified
A Systems Genetics Approach Implicates USF1, FADS3, and Other Causal Candidate Genes for Familial Combined Hyperlipidemia
Plaisier, C. L., Horvath, S., Huertas-Vazquez, A., Cruz-Bautista, I., Herrera, M. F., Tusie-Luna, T., Aguilar-Salinas, C., & Pajukanta, P. (2009) · PLoS Genetics
Genetic Associations and EpidemiologyLipid metabolism and disorders
Cited by 163
- Verified
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
Rusu, V., Hoch, E., Mercader, J. M., Tenen, D. E., Gymrek, M., Hartigan, C. R., DeRan, M., von Grotthuss, M., Fontanillas, P., Spooner, A., et al. (2017) · Cell
Genetic Associations and EpidemiologyMetabolism, Diabetes, and Cancer
Cited by 152
- Verified
The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: A placebo-controlled, randomized clinical trial
Caballero, A. E., Delgado, A., Aguilar-Salinas, C. A., Herrera, A. N., Castillo, J. L., Cabrera, T., Gomez-Perez, F. J., & Rull, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism
Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 151
- Verified
Fibroblast growth factor 21 and browning of white adipose tissue
Cuevas-Ramos, D., Mehta, R., & Aguilar-Salinas, C. A. (2019) · Frontiers in Physiology
Adipose Tissue and MetabolismFibroblast Growth Factor Research
Cited by 149
- Verified
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology
Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health
Cited by 140
- Verified
A Dietary Pattern Including Nopal, Chia Seed, Soy Protein, and Oat Reduces Serum Triglycerides and Glucose Intolerance in Patients with Metabolic Syndrome
Guevara-Cruz, M., Tovar, A. R., Aguilar-Salinas, C. A., Medina-Vera, I., Gil-Zenteno, L., Hernández-Viveros, I., López-Romero, P., Ordaz-Nava, G., Canizales-Quinteros, S., Guillen Pineda, L. E., et al. (2012) · The Journal of Nutrition
Nutritional Studies and DietNutrition, Genetics, and Disease
Cited by 132
- Verified
Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006
Aguilar-Salinas, C. A., Gómez-Pérez, F. J., Rull, J., Villalpando, S., Barquera, S., & Rojas, R. (2010) · Salud Pública de México
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 117
- Verified
Strong association of socioeconomic status with genetic ancestry in Latinos: Implications for admixture studies of type 2 diabetes
Florez, J. C., Price, A. L., Campbell, D., Riba, L., Parra, M. V., Yu, F., Duque, C., Saxena, R., Gallego, N., Tello-Ruiz, M., et al. (2009) · Diabetologia
Race, Genetics, and SocietyGenetic Associations and Epidemiology
Cited by 106
- Verified
The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
Aguilar-Olivos, N. E., Almeda-Valdes, P., Aguilar-Salinas, C. A., Uribe, M., & Méndez-Sánchez, N. (2016) · Metabolism
Bariatric Surgery and OutcomesLiver Disease Diagnosis and Treatment
Cited by 100
- Verified
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
NCD Risk Factor Collaboration (NCD-RisC), Zhou, B., Sheffer, K. E., Bennett, J. E., Gregg, E. W., Danaei, G., Singleton, R. K., Shaw, J. E., Mishra, A., Lhoste, V. P. F., et al. (2023) · Nature Medicine
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 94
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free